tiprankstipranks
Trending News
More News >
Elevance Health (ELV)
NYSE:ELV
US Market
Advertisement

Elevance Health (ELV) Ratios

Compare
2,835 Followers

Elevance Health Ratios

ELV's free cash flow for Q2 2025 was $1.00. For the 2025 fiscal year, ELV's free cash flow was decreased by $ and operating cash flow was $0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.30 2.05 1.40 2.07 2.13
Quick Ratio
1.30 2.05 1.69 3.86 3.96
Cash Ratio
0.20 0.25 0.19 0.23 0.31
Solvency Ratio
0.09 0.11 0.11 0.12 0.11
Operating Cash Flow Ratio
0.15 0.31 0.21 0.39 0.57
Short-Term Operating Cash Flow Coverage
3.21 4.30 4.76 4.46 15.27
Net Current Asset Value
$ -21.10B$ -15.52B$ -10.76B$ -16.59B$ -13.28B
Leverage Ratios
Debt-to-Assets Ratio
0.25 0.23 0.23 0.24 0.23
Debt-to-Equity Ratio
0.69 0.64 0.66 0.64 0.60
Debt-to-Capital Ratio
0.41 0.39 0.40 0.39 0.38
Long-Term Debt-to-Capital Ratio
0.39 0.37 0.38 0.37 0.37
Financial Leverage Ratio
2.79 2.77 2.83 2.70 2.61
Debt Service Coverage Ratio
2.45 3.02 3.22 1.56 4.39
Interest Coverage Ratio
5.33 8.49 9.93 11.21 9.84
Debt to Market Cap
0.43 0.23 0.20 0.20 0.25
Interest Debt Per Share
139.55 112.20 104.02 97.74 83.01
Net Debt to EBITDA
2.19 1.77 1.65 3.02 1.75
Profitability Margins
Gross Profit Margin
100.00%27.44%25.51%25.96%27.75%
EBIT Margin
4.43%5.10%5.40%3.39%5.76%
EBITDA Margin
5.22%6.12%6.47%4.33%6.71%
Operating Profit Margin
3.73%5.10%5.40%6.45%6.33%
Pretax Profit Margin
3.73%4.50%4.85%5.72%5.12%
Net Profit Margin
2.83%3.49%3.76%4.40%3.75%
Continuous Operations Profit Margin
2.83%3.50%3.76%4.44%3.75%
Net Income Per EBT
75.83%77.60%77.55%77.02%73.29%
EBT Per EBIT
100.00%88.22%89.93%88.59%80.90%
Return on Assets (ROA)
4.40%5.50%5.74%6.27%5.28%
Return on Equity (ROE)
12.51%15.23%16.23%16.93%13.77%
Return on Capital Employed (ROCE)
9.05%10.58%13.40%11.80%11.37%
Return on Invested Capital (ROIC)
7.25%8.04%10.07%7.44%6.88%
Return on Tangible Assets
6.53%8.16%8.66%9.77%8.24%
Earnings Yield
7.61%5.45%4.79%5.40%5.68%
Efficiency Ratios
Receivables Turnover
8.18 9.59 17.48 17.87 21.46
Payables Turnover
0.00 5.40 20.80 5.55 5.22
Inventory Turnover
0.00 0.00 -10.25 -2.67 -2.56
Fixed Asset Turnover
40.78 39.31 36.28 35.38 34.99
Asset Turnover
1.55 1.57 1.52 1.42 1.41
Working Capital Turnover Ratio
11.99 6.46 8.03 6.25 6.07
Cash Conversion Cycle
44.60 -29.53 -32.27 -182.16 -195.18
Days of Sales Outstanding
44.60 38.06 20.89 20.43 17.01
Days of Inventory Outstanding
0.00 0.00 -35.61 -136.84 -142.32
Days of Payables Outstanding
0.00 67.58 17.55 65.74 69.86
Operating Cycle
44.60 38.06 -14.73 -116.42 -125.31
Cash Flow Ratios
Operating Cash Flow Per Share
28.58 34.59 35.00 34.31 42.62
Free Cash Flow Per Share
23.64 29.03 30.20 29.85 38.54
CapEx Per Share
4.95 5.56 4.80 4.46 4.07
Free Cash Flow to Operating Cash Flow
0.83 0.84 0.86 0.87 0.90
Dividend Paid and CapEx Coverage Ratio
2.45 3.00 3.53 3.82 5.41
Capital Expenditure Coverage Ratio
5.78 6.22 7.29 7.69 10.47
Operating Cash Flow Coverage Ratio
0.21 0.32 0.35 0.36 0.53
Operating Cash Flow to Sales Ratio
0.03 0.05 0.05 0.06 0.09
Free Cash Flow Yield
7.60%6.16%5.89%6.44%12.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
13.25 18.36 20.89 18.51 17.61
Price-to-Sales (P/S) Ratio
0.37 0.64 0.79 0.82 0.66
Price-to-Book (P/B) Ratio
1.62 2.80 3.39 3.13 2.43
Price-to-Free Cash Flow (P/FCF) Ratio
13.27 16.25 16.99 15.53 8.33
Price-to-Operating Cash Flow Ratio
11.00 13.63 14.66 13.51 7.53
Price-to-Earnings Growth (PEG) Ratio
-1.56 3.98 -10.93 0.50 -5.67
Price-to-Fair Value
1.62 2.80 3.39 3.13 2.43
Enterprise Value Multiple
9.36 12.25 13.81 21.85 11.60
Enterprise Value
91.83B 128.50B 139.84B 131.16B 94.82B
EV to EBITDA
9.30 12.25 13.81 21.85 11.60
EV to Sales
0.49 0.75 0.89 0.95 0.78
EV to Free Cash Flow
17.21 18.99 19.30 18.02 9.81
EV to Operating Cash Flow
14.23 15.94 16.65 15.68 8.87
Tangible Book Value Per Share
17.68 16.37 7.07 5.27 8.39
Shareholders’ Equity Per Share
193.63 168.64 151.28 147.91 132.37
Tax and Other Ratios
Effective Tax Rate
0.24 0.22 0.23 0.23 0.27
Revenue Per Share
838.15 735.14 652.48 568.66 485.91
Net Income Per Share
23.74 25.69 24.56 25.04 18.23
Tax Burden
0.76 0.78 0.78 0.77 0.73
Interest Burden
0.84 0.88 0.90 1.69 0.89
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.10 1.35 1.40 1.37 2.34
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis